Global Business Report interview with Șirin Deha, Founder & GM of Era Pharma Solutions Șirin Deha - FOUNDER & GM ERA PHARMA SOLUTIONS
Could you start by bringing our audience up to date with the latest development at Era Pharma?
Era Pharma is the only accredited independent R&D laboratory for pharma industry in Turkey. In the latest of our achievements, Era was audited by the Ministry of Health as a pre-requisite
Visit to President of the Medical Devices and Drug Administration authority (TİTCK), Mr. Hakkı Gürsöz (18 F2020) President of the Medical Devices and Drug Administration authority (TİTCK), Mr. Hakkı Gürsöz have accepted us. Together with the Licensing and Pricing managers of the leading companies in the pharmaceutical industry, we visited Mr. Gürsöz and shared the problems on the agenda of his sector and exchanged views (18.02.2020)
Our general manager Şirin Deha has participated in the 5th International Congress on Drug Design as a speaker On October 19-21, at the 5th International Congress of Drug Design in Bahçeşehir University Faculty of Medicine, Mrs. Şirin Deha, our General Manager, participated as a speaker.
Your browser does not support the video tag.
İlaç Araştırma ve Geliştirme Uluslararası Çok Disiplinli 2017 Sempozyumu (DRD-2017) (5 EKİM 2017) Eczacılık ve Tıp Araştırmacıları Derneği (ILARUD)” ve Atatürk Üniversitesi tarafından ortaklaşa düzenlen, İlaç Araştırma ve Geliştirme Uluslararası Çok Disiplinli 2017 Sempozyumu (DRD-2017) Erzurum’da gerçekleşmiştir. Sayın Başkanımız Sağlık E.Bakanı Ecz. M.Kazım DİNÇ ve Yönetim Kurulu Üyemiz Sayın Şirin DEHA katılım sağlamışlardır.
Turkey Pharmaceuticals Manufacturing 2014 In establishing ERA Pharma Solutions, what was your vision and mission?
ERA Pharma Solutions was the first independent contract R&D business to establish itself in Turkey. We focus specifically on pharmaceuticals. In Turkey, there are many R&D-focused businesses, but they all belong to larger pharmaceutical companies. In Europe, people are familiar with independent, quality control and
Our quality system is approved by TS EN ISO/IEC 17025 Laboratory Quality Certificate Era Pharma quality system is approved by TS EN ISO/IEC 17025 certification. “Subcontractor Laboratory Approval” ISO/IEC 17025 is a certificate for “General requirements for the competence of testing and calibration laboratories”. Scope of certificate is regarding to assay and impurity analyses that performed with chromatographic methods (HPLC, GC) and Dissolution tests for “Pharmaceutical products, active
Era Pharma in the Leading Pharma Event of the year We took our part in the Leading Pharma Event of the year, CPhI Istanbul 2014 which was held between 4-6 June 2014 at Lutfi Kirdar Convention and Exhibition Center. We had a successful event thanks to the interest of a high number of pharmaceutical professionals from Turkey and abroad who visited Era Pharma booth.
We were in Europharma SMC Era Pharma participated to 11th International meeting of Europharm SMC in Istanbul. Delegates from 16 different countries small and medium sized pharmaceutical companies come together in this meeting.We had chance to introduce our activities and find some partnership opportunities.
Strategic Partner of Pharmaceutical Companies : Era Pharma
W- Can you shortly introduce us Erapharma and yourself?
Ş.D.- ERA Pharma Solutions is a world class R&D and contract analytical services to pharmaceutical industry to provide tailored, innovative solutions to client requirements, founded in 2010. Era Pharma Solutions is the first independent R&D organization dedicated to pharmaceuticals development process in Turkey who includes an internal
Era Pharma has participated in CPhI Istanbul 2016 Domestically and abroad pharmaceutical professionals, participated to the world's leading pharmaceutical industry event CPhI 2016 and there interest was high.
We as EraPharma, are pleased to come together with you at our booth and introduce our technology transfer, formulation & process development, instrumental analysis, licensing, generic drug development and R & D services.